80 likes | 151 Views
Get more details @ http://bit.ly/2es3cSk <br>Global HIV diagnostics market share is competitive, garnered by the presence of number of large firms, and various small players. Roche Diagnostics, Siemens Healthcare, Abbott Healthcare, and Alere, Inc are major players in the market.
E N D
HIV Diagnostics Market share to reach $4.9bn by 2023:Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024
Key Insights from HIV Diagnostics Market: • Global HIV Diagnostics Market size contributed about $2.41 billion for 2015 and is expected to register CAGR of about 9.6% by end of forecast period. • Rising cases of HIV (human immunodeficiency virus) and fast medical breakthroughs in terms of point of care diagnostics is predicted to drive HIV diagnostics market trends during forecast timeline. • HIV is found to be most common ailment, particularly in resource limited areas due to low health consciousness among the people and successful execution of antiretroviral treatment program. • Global HIV diagnostics industry is segmented into various products like viral load, early infant diagnosis, antibody tests, viral identification assay and CD4. • Antibody tests segment is sub-segmented into western blot tests, HIV-1 screening tests, dried blood spot tests, ELISA (enzyme linked immunosorbent assay) tests, HIV- confirmatory tests, rapid test, western blot tests, line immunoassay, blood anti body tests, RIPA (radio immuno precipitation assay) tests, HIV-2 & group O tests and indirect immunofluorescent antibody assay (IIFA) tests.
Continued... • This segment is predicted to contribute largely to HIV diagnostics market share during forecast timeline and is projected to surpass $1.6 billion by end of 2023. • Viral identification assay segment is sub-segmented into viral culture, p24 antigen and qualitative PCR (polymerase chain reaction). Viral culture assay sub segment projected to touch $530 million by end of 2023 led the segment. • Viral load and CD4 segments are projected to register comparatively high CAGR of 9.91% and 10.2% during forecast timeline owing to increasing industry penetration as well as expansion of point of care diagnostics methods for such tests that would improve marketability in limited resource settings. • North America HIV diagnostics market price was evaluated at $947 million for 2015 and it dominated the global industry during the year. • Asia Pacific HIV diagnostics industry is projected to register CAGR of 10.8% during forecast timeline due to enhancement in healthcare services coupled with rise in levels of HIV consciousness amongst the population of the region.
Table of Content: Chapter 1. Methodology and Scope 1.1. Methodology 1.1.1. Initial data exploration 1.1.2. Statistical modeling and forecast 1.1.3. Industry insights and validation 1.2. Data Sources Chapter 2. Executive Summary 2.1. HIV diagnostics industry 3600 synopsis, 2012 - 2023 2.1.1. Business trends 2.1.2. Regional trends 2.1.3. Application trends
Table of Content: Chapter 3. HIV Diagnostics Industry Insights 3.1. Industry segmentation 3.2. Industry size and forecast, 2012 - 2023 3.3. Industry impact forces 3.3.1. Growth drivers 3.3.1.1. Favorably regulatory landscape 3.3.1.2. PoC HIV diagnostics development 3.3.1.3. Increasing HIV/AIDS prevalence 3.3.2. Industry pitfalls & challenges 3.3.2.1. Low degree of penetration in undeveloped regional markets 3.4. Growth potential analysis 3.5. Porter’s analysis 3.6. PESTEL analysis
U.S. HIV Diagnostics Market Size, by Product, 2012 - 2023 (USD Million)
Browse Full Market Research Report On HIV Diagnostics Market @ http://bit.ly/2p3JDIj Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/491
Stay In Touch Website: www.gminsights.com Social Media: